Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2008-01-22
2010-11-09
Tsang, Cecilia (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
Reexamination Certificate
active
07829666
ABSTRACT:
Derivatives of Maurotoxin (MTX) in which the native disulfide bridge pattern (Cys3-Cys24, Cys9-Cys29, Cys19, Cys31-Cys34) has been disrupted are useful for the treatment of pathologies associated with dysfunctioning and/or activation of Ca2+-activated and/or voltage-gated K+channel subtypes, such as IKCa1 or Kv1.2. In one group of derivatives, one or two of the amino acid residues of maurotoxin have been replaced by different amino acid residues resulting in the disulfide bridge pattern being changed to Cys3-Cys24, Cys9-Cys29, Cys13-Cys31, Cys19-Cys34. Exemplary substitutions include the Arg residue at position 14 and/or the Lys residue at position 15 replaced by a Gln residue and the Gly residue at position 33 replaced by an Ala residue. Pi1 and HsTx1 derivatives with disrupted native disulfide bridge patterns are similarly useful.
REFERENCES:
patent: 5945329 (1999-08-01), Breddam et al.
patent: PCT/US92/08595 (1991-10-01), None
patent: PCT/US97/08074 (1996-05-01), None
patent: PCT/EP97/07333 (1996-12-01), None
Blanc E. et al, “Solution Structure of Maurotoxin, a Scorpion Toxin FromScorpio maurus, With High Affinity for Voltage-Gated Potassium Channels,”. Proteins: Structure, Function, and Genetics 29 (1997); 321-333.
Blanc E. et al, “Solution Structure of Maurotoxin, a Scorpion Toxin FromScorpio maurus, With High Affinity for Voltage-Gated Potassium Channels,”. Proteins: Structure, Function, and Genetics 29 (1997) XP-001057482; 321-333.
Carlier E. et al, “Effect of maurotoxin, a four disulfide-bridged toxin from the chactoid scorpionScorpio maurus, onShakerK+channels,”. J. Peptide Res. 55, (2000) XP-000947132; 419-427.
Carlier E. et al, “Disulfide bridge reorganization induced by proline mutations in maurotoxin,”. FEBS Letters 489 (2001); 202-207.
Fajloun Z. et al, “MaurotoxinVersusPi1/HsTx1 Scorpion Toxins,”. The Journal of Biological Chemistry vol. 275, No. 50 (2000) XP-002198493; 39394-39402.
Fajloun Z. et al, “Synthesis,1H NMR Structure, and Activity of a Three-disulfide-bridged Maurotoxin Analog Designed to Restore the Consensus Motif of Scorpion Toxins,”. The Journal of Biological Chemistry vol. 275, No. 18 (2000) XP-002190859; 13605-13612.
Kharrat R. et al, “Maurotoxin, a four disulfide bridge toxin fromScorpio maurusvenom: purification, structure and action on potassium channels,”. FEBS Letters 406 (1997); 284-290.
Lecomte C. et al, “Maurotoxin and the KV1.1channel: voltage-dependent binding upon enantiomerization of the scorpion toxin disulfide bridge Cys31-Cys34,”. J. Peptide Res. 55, (2000) XP-002190858; 246-254.
Olamendi-Portugal T. et al, “A novel structural class of K+-channel blocking toxin from the scorpionPandinus imperator,”. Biochem. J. (1996) 315; 977-981.
Sabatier J.-M. et al., “Maurotoxin vs PI1 Scorpion Toxins: Towards New Insights In The Understanding Of Their Distinct Disulfide Bridge Patterns,”. p. 216 (2000) XP-001057491; S 152.
Sabatier J.-M. et al., “Synthesis and Characterization of Leiurotoxin I Analogs Lacking One Disulfide Bridge: Evidence That Disulfide Pairing 3-21 Is Not Required for Full Toxin Activity,”. Biochemistry (1996) 35 XP-002064839; 10641-10647.
Savarin P. et al., “Structural and functional consequenses of the presence of a fourth disulfide bridge in the scorpion short toxins: solution of the potassium channel inhibitor HsTX1,”. Protein Science (1999); 2672-2685.
Tytgat J. et al., “A unified nomenclature for short-chain peptides isolated from scorpion venoms: α-KTx molecular subfamilies,”. Nov. 1999 vol. 20.
Zhukov I. et al., “Conservative mutation Met8 → Leu affects the folding process and structural stability of squash trypsin inhibitor CMTI-I,”. Protein Science (2000); 273-279.
Mabrouk Kamel
Rochat Herve
Sabatier Jean-Marc
Cellpep Pharma Inc.
Clark & Elbing LLP
Heard Thomas S
Tsang Cecilia
LandOfFree
Maurotoxin, PI1 and HSTX1 derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Maurotoxin, PI1 and HSTX1 derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Maurotoxin, PI1 and HSTX1 derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4209751